NOVEL INHIBITORS OF CHANNEL ACTIVATING PROTEASES: IMPLICATIONS FOR CYSTIC FIBROSIS LUNG DISEASE.

Medicine and Dentistry

• Cystic Fibrosis 100%
• Silo-Filler's Disease 100%
• Epithelial Sodium Channel 100%
• Protease 100%
• Proteinase Activated Receptor 2 50%
• Real-Time Polymerase Chain Reaction 33%
• Proteinase Inhibitor 33%
• Enzyme Linked Immunosorbent Assay 33%
• Secretion (Process) 33%
• Mucociliary Clearance 33%
• Calcium Mobilization 33%
• Interleukin 6 33%
• Sodium Absorption 33%
• Infection 16%
• Cytokine 16%
• Tumor Necrosis Factor 16%
• Lactate Dehydrogenase 16%
• Inflammatory Mediator 16%
• Lung Epithelium 16%
• Tryptase 16%
• Inflammation 16%
• Cell Line 16%
• Cytotoxicity 16%
• Peptide 16%

Immunology and Microbiology

• Lung 100%
• Proteinase 100%
• Interleukin 8 60%
• Real-Time Polymerase Chain Reaction 40%
• ELISA 40%
• Secretion (Process) 40%
• Sodium Absorption 40%
• Interleukin 6 40%
• Airway 40%
• Mucociliary Clearance 40%
• Calcium Mobilization 40%
• Protease 40%
• Inflammation 20%
• Infectious Disease 20%
• Tumor Necrosis Factor 20%
• Cell Line 20%
• Mediator 20%
• Cytokine 20%
• Cytotoxicity 20%
• Peptides 20%
• Infection 20%
• Sodium Channel 20%
• Lactic Acid 20%
• Lactate 20%
• Lung Epithelium 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Disease 100%
• Cystic Fibrosis 100%
• Epithelial Sodium Channel 100%
• Proteinase Activated Receptor 2 50%
• Enzyme-Linked Immunosorbent Assay 33%
• Proteinase Inhibitor 33%
• Interleukin 6 33%
• Sodium 33%
• Cytokine 16%
• Infection 16%
• Inflammation 16%
• Tumor Necrosis Factor 16%
• Tryptase 16%
• Cytotoxicity 16%
• Lactate Dehydrogenase 16%
• Peptide 16%